The present invention relates to prevention and treatment of strokes and
ischemic diseases and to post-ischemic therapeutic treatment. The
invention furthermore relates to the use of a growth factor or nucleic
acids ensuring increased expression of a growth factor for treating, more
particularly restoring the function of ischemic tissue, in particular
muscles such as myocardium and skeletal muscles.